Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

✍ Scribed by R. Coleman; E. Woodward; J. Brown; D. Cameron; R. Bell; D. Dodwell; M. Keane; M. Gil; C. Davies; R. Burkinshaw; S. J. Houston; R. J. Grieve; P. J. Barrett-Lee; H. Thorpe

• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 339 KB
• Volume: 127
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-011-1429-y